A recent study confirmed the concept of the high expression of CD40, HLA-DR, and IL-21R in the activated naïve B cells of patients with SLE, whose interaction with CD4 T cells contributes to the pathogenesis of the disease [36]. This evidence concerns the gene CD4 and systemic lupus erythematosus.